Chronic kidney disease progression - PubMed (original) (raw)

. 2006 Nov;17(11):2964-6.

doi: 10.1681/ASN.2006070704. Epub 2006 Oct 11.

Affiliations

• PMID: 17035605
• DOI: 10.1681/ASN.2006070704

Chronic kidney disease progression

Allison A Eddy et al. J Am Soc Nephrol. 2006 Nov.

No abstract available

PubMed Disclaimer

Similar articles

• Relationship between chronic kidney disease prevalence and end-stage renal disease risk.
  Hallan SI, Vikse BE. Hallan SI, et al. Curr Opin Nephrol Hypertens. 2008 May;17(3):286-91. doi: 10.1097/MNH.0b013e3282f8b177. Curr Opin Nephrol Hypertens. 2008. PMID: 18408480 Review.
• Linking the population epidemiology of acute renal failure, chronic kidney disease and end-stage renal disease.
  Hsu CY. Hsu CY. Curr Opin Nephrol Hypertens. 2007 May;16(3):221-6. doi: 10.1097/MNH.0b013e3280895ad9. Curr Opin Nephrol Hypertens. 2007. PMID: 17420665 Review. No abstract available.
• Progression of chronic kidney disease in children with vesicoureteral reflux: the North American Pediatric Renal Trials Collaborative Studies Database.
  Novak TE, Mathews R, Martz K, Neu A. Novak TE, et al. J Urol. 2009 Oct;182(4 Suppl):1678-81. doi: 10.1016/j.juro.2009.02.085. Epub 2009 Aug 18. J Urol. 2009. PMID: 19692051
• Editorial comment.
  Kitchens DM. Kitchens DM. J Urol. 2009 Oct;182(4 Suppl):1682. doi: 10.1016/j.juro.2009.02.259. Epub 2009 Aug 18. J Urol. 2009. PMID: 19692052 No abstract available.
• Epstein syndrome with rapid progression to end stage renal disease.
  Alhindawi E, Al-Jbour S. Alhindawi E, et al. Saudi J Kidney Dis Transpl. 2009 Nov;20(6):1076-8. Saudi J Kidney Dis Transpl. 2009. PMID: 19861875

Cited by

• Nodakenin alleviated obstructive nephropathy through blunting Snail1 induced fibrosis.
  Li J, Wang L, Tan R, Zhao S, Zhong X, Wang L. Li J, et al. J Cell Mol Med. 2020 Sep;24(17):9752-9763. doi: 10.1111/jcmm.15539. Epub 2020 Jul 22. J Cell Mol Med. 2020. PMID: 32696548 Free PMC article.
• MicroRNA-214 antagonism protects against renal fibrosis.
  Denby L, Ramdas V, Lu R, Conway BR, Grant JS, Dickinson B, Aurora AB, McClure JD, Kipgen D, Delles C, van Rooij E, Baker AH. Denby L, et al. J Am Soc Nephrol. 2014 Jan;25(1):65-80. doi: 10.1681/ASN.2013010072. Epub 2013 Oct 24. J Am Soc Nephrol. 2014. PMID: 24158985 Free PMC article.
• Brilliant blue G, a P2X7 receptor antagonist, attenuates early phase of renal inflammation, interstitial fibrosis and is associated with renal cell proliferation in ureteral obstruction in rats.
  Pereira JMS, Barreira AL, Gomes CR, Ornellas FM, Ornellas DS, Miranda LC, Cardoso LR, Coutinho-Silva R, Schanaider A, Morales MM, Leite M Jr, Takiya CM. Pereira JMS, et al. BMC Nephrol. 2020 May 29;21(1):206. doi: 10.1186/s12882-020-01861-2. BMC Nephrol. 2020. PMID: 32471386 Free PMC article.
• Transcriptome Identified lncRNAs Associated with Renal Fibrosis in UUO Rat Model.
  Sun J, Zhang S, Shi B, Zheng D, Shi J. Sun J, et al. Front Physiol. 2017 Aug 31;8:658. doi: 10.3389/fphys.2017.00658. eCollection 2017. Front Physiol. 2017. PMID: 28912732 Free PMC article.
• Structural equation modeling highlights the potential of Kim-1 as a biomarker for chronic kidney disease.
  Gardiner L, Akintola A, Chen G, Catania JM, Vaidya V, Burghardt RC, Bonventre JV, Trzeciakowski J, Parrish AR. Gardiner L, et al. Am J Nephrol. 2012;35(2):152-63. doi: 10.1159/000335579. Epub 2012 Jan 20. Am J Nephrol. 2012. PMID: 22269876 Free PMC article.

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Wolters Kluwer

• Medical

  • MedlinePlus Health Information